0001179110-19-010357.txt : 20190916
0001179110-19-010357.hdr.sgml : 20190916
20190916155852
ACCESSION NUMBER: 0001179110-19-010357
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190905
FILED AS OF DATE: 20190916
DATE AS OF CHANGE: 20190916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prause Burkhard
CENTRAL INDEX KEY: 0001544726
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 191094727
MAIL ADDRESS:
STREET 1: BRUKER CORPORATION
STREET 2: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
4/A
1
edgar.xml
FORM 4/A -
X0306
4/A
2019-09-05
2019-09-09
0
0001109354
BRUKER CORP
BRKR
0001544726
Prause Burkhard
BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
0
1
0
0
Pres. & CEO, Bruker EST
Common Stock
2019-09-05
4
M
0
3718
20.68
A
20758
D
Common Stock
2019-09-05
4
M
0
9984
19.82
A
30742
D
Common Stock
2019-09-05
4
M
0
2000
22.19
A
32742
D
Common Stock
17040
D
Stock Option (Right to Buy)
20.68
2019-09-05
4
M
0
3718
0
D
2024-08-08
Common Stock
3718
0
D
Stock Option (Right to Buy)
19.82
2019-09-05
4
M
0
9984
0
D
2025-08-07
Common Stock
9984
0
D
Stock Option (Right to Buy)
22.19
2019-09-05
4
M
0
2000
0
D
2026-10-04
Common Stock
2000
0
D
The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction.
The option vested in four approximately equal annual installments on August 8, 2015, 2016, 2017 and 2018.
The option vested in four approximately equal annual installments on August 7, 2016, 2017, 2018 and 2019.
The option vested partially in two annual installments on October 4, 2017 and 2018 with two installments remaining to vest on October 4, 2019 and 2020.
/s/ Michael Rich, Attorney-in-Fact
2019-09-16